Iberogast N

Extract of Iberis Amara, the active ingredient in Iberogast N, is a herbal preparation presented as a liquid oral drops for oral use. It is used to relieve functional dyspepsia, irritable bowel syndrome and other gastrointestinal discomfort in adults. GNH USA supplies Iberogast N as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Iberogast N is indicated for functional gastrointestinal disorders that involve motility disturbance and visceral hypersensitivity. - Functional dyspepsia: helps reduce upper abdominal pain, bloating and early satiety. - Irritable bowel syndrome: alleviates abdominal cramps, irregular bowel habits and discomfort. - Gastrointestinal discomfort: eases non‑specific stomach upset, nausea and mild indigestion.

Adverse reactions are generally mild and reversible.

Common Side Effects: - Altered taste sensation - Mild nausea or stomach discomfort - Diarrhoea or loose stools - Headache - Skin redness at the oral mucosa

Serious or Rare Side Effects: - Allergic reactions such as urticaria or angio‑edema - Anaphylactic shock (rare) - Hepatotoxicity reported in isolated cases - Severe abdominal pain not relieved by therapy - Persistent vomiting or dehydration

Before using Iberogast N, consider the following safety points. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: discuss potential risks with a physician. - Known hypersensitivity: avoid if you have a documented allergy to any component of the formulation. - Liver disease: use with caution and under medical supervision. - Concomitant medications: inform your doctor about all medicines you are taking. - Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and direct sunlight.

Iberogast N may affect the activity of certain drugs; monitor accordingly.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Potent CYP3A4 inhibitors (e.g., ketoconazole): possible alteration of herbal constituent metabolism.

Moderate Interactions (Monitor Closely): - Other gastrointestinal motility agents: additive spasmolytic effect. - Antacids: may affect absorption of some herbal components. - Immunosuppressants: potential for altered immune response.